Ma Kuang Healthcare Holding Limited (TPEX:4139)
Taiwan · Delayed Price · Currency is TWD 23.75
-0.65 (-2.66%)
At close: Feb 11, 2026
TPEX:4139 Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| 1,104 | 1,130 | 1,218 | 1,059 | 959.45 | 910.24 | |
Revenue Growth (YoY) | -4.46% | -7.21% | 15.05% | 10.35% | 5.41% | -10.78% |
Cost of Revenue | 963.51 | 979.79 | 1,046 | 898.05 | 786.29 | 734.83 |
Gross Profit | 140.72 | 150.47 | 171.77 | 160.7 | 173.16 | 175.41 |
Selling, General & Admin | 118.05 | 123.91 | 128.69 | 108.22 | 107.69 | 115.24 |
Amortization of Goodwill & Intangibles | 1.23 | 1.24 | 1.18 | 1.14 | 1.13 | - |
Operating Expenses | 135.24 | 135.48 | 146.98 | 122.7 | 127.53 | 114.52 |
Operating Income | 5.48 | 14.99 | 24.79 | 37.99 | 45.64 | 60.89 |
Interest Expense | -39.53 | -44.38 | -43.33 | -26.72 | -22.47 | -21.06 |
Interest & Investment Income | 8.97 | 8.84 | 2.56 | 8.48 | 10.7 | 10.59 |
Earnings From Equity Investments | - | - | - | -23.95 | - | -1.72 |
Currency Exchange Gain (Loss) | 0.44 | -8.41 | 0.54 | -12.66 | -1.82 | 5.19 |
Other Non Operating Income (Expenses) | 27.48 | 46.16 | -6.38 | -7.74 | 29.75 | 53.53 |
EBT Excluding Unusual Items | 2.84 | 17.19 | -21.83 | -24.6 | 61.79 | 107.43 |
Impairment of Goodwill | -11.18 | -6.66 | -7.12 | -5.88 | -5.21 | - |
Gain (Loss) on Sale of Assets | -2.36 | -0.36 | 0.05 | -1.16 | - | 0 |
Other Unusual Items | 9.34 | 0.56 | 0.46 | 1.45 | - | - |
Pretax Income | -1.36 | 10.73 | -28.44 | -30.18 | 56.58 | 107.43 |
Income Tax Expense | 16.11 | 11.75 | 11.18 | 5.34 | 14.62 | 7.95 |
Earnings From Continuing Operations | -17.47 | -1.02 | -39.62 | -35.52 | 41.96 | 99.48 |
Minority Interest in Earnings | 11.42 | 11.3 | -2.91 | 4.62 | -3.42 | -22.32 |
Net Income | -6.05 | 10.28 | -42.53 | -30.9 | 38.54 | 77.16 |
Net Income to Common | -6.05 | 10.28 | -42.53 | -30.9 | 38.54 | 77.16 |
Net Income Growth | - | - | - | - | -50.05% | 14.12% |
Shares Outstanding (Basic) | 43 | 43 | 43 | 43 | 43 | 43 |
Shares Outstanding (Diluted) | 43 | 43 | 43 | 43 | 43 | 43 |
Shares Change (YoY) | 0.58% | - | - | -0.10% | -0.03% | 0.08% |
EPS (Basic) | -0.14 | 0.24 | -1.00 | -0.73 | 0.91 | 1.81 |
EPS (Diluted) | -0.15 | 0.24 | -1.00 | -0.73 | 0.90 | 1.81 |
EPS Growth | - | - | - | - | -50.28% | 13.90% |
Free Cash Flow | 234.5 | 313.48 | 162.95 | 48.04 | 191.77 | 284.15 |
Free Cash Flow Per Share | 5.48 | 7.37 | 3.83 | 1.13 | 4.50 | 6.67 |
Dividend Per Share | - | - | - | - | - | 1.600 |
Dividend Growth | - | - | - | - | - | 28.76% |
Gross Margin | 12.74% | 13.31% | 14.10% | 15.18% | 18.05% | 19.27% |
Operating Margin | 0.50% | 1.33% | 2.04% | 3.59% | 4.76% | 6.69% |
Profit Margin | -0.55% | 0.91% | -3.49% | -2.92% | 4.02% | 8.48% |
Free Cash Flow Margin | 21.24% | 27.73% | 13.38% | 4.54% | 19.99% | 31.22% |
EBITDA | 49.04 | 59.04 | 66.19 | 69.54 | 72.18 | 85.15 |
EBITDA Margin | 4.44% | 5.22% | 5.43% | 6.57% | 7.52% | 9.35% |
D&A For EBITDA | 43.55 | 44.05 | 41.4 | 31.55 | 26.54 | 24.26 |
EBIT | 5.48 | 14.99 | 24.79 | 37.99 | 45.64 | 60.89 |
EBIT Margin | 0.50% | 1.33% | 2.04% | 3.59% | 4.76% | 6.69% |
Effective Tax Rate | - | 109.49% | - | - | 25.84% | 7.40% |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.